News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kirin Brewery Co., Ltd. (KNBWY) , Sankyo Company, Ltd. (SKXOF.PK) To Terminate Joint Marketing Of Renal Anemia Drug ESPO And Leukopenia Drug GRAN By Next March


10/19/2005 5:11:50 PM

Leading Japanese beverage manufacturer Kirin Brewery (TSE:2503) announced that it has mutually agreed with Sankyo (TSE:4501) to terminate their agreement on joint sales of ESPO, a renal anemia drug, and GRAN, a leukopenia, by the end of March 2005. Consequently, Kirin will sell ESPO and GRAN as a sole distributor from April 2005.

Read at JCN Newswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES